Case Report
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 5076-5085
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.5076
Table 1 Characteristics of 16 transplanted patients with gastrointestinal stromal tumors

Overall number

Male sex, n (%)1611 (69)
Age (yr), median (min; max)1659.5 (23; 74)
Type of organ transplantation, n (%)16
Kidney12 (75)
Liver4 (25)
Location of primitive tumor, n (%) 16
Stomach9 (56)
Small bowel3 (19)
Colon1 (6)
Other: pelvis, perineum, mesentery3 (19)
Time from transplantation to diagnosis (mo), median (min; max)1632 (5; 252)
Metastatic dissemination at diagnosis, n (%)160 (0)
Tumor size (mm), median (min; max)1545 (10; 230)
Risk of progression according to Joensuu’s criteria, n (%)14
Very low2 (14)
Low4 (29)
Intermediate2 (14)
High6 (43)
Surgical treatment, n (%) 1615 (94)
Adjuvant treatment, n (%)163 (19)
Modification of immunosuppression, n (%)119 (82)
Death during follow-up, n (%) 144 (29)